GlassScriptPhysician profile
Darrin James Trask
NPI 1487997862
$8,643.92
in general payments reported to CMS, 2019-2025
12 companies · $1,768 in 2025
The $1,768 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,744 · 2020: $452 · 2021: $125 · 2022: $1,267 · 2023: $914 · 2024: $1,374 · 2025: $1,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,026 · Food and Beverage: $1,780 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,026.16 |
| Food and Beverage | $1,779.77 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,290.14 | 2019-2025 | Mako, Triathlon, Gamma |
| Zimmer Biomet Holdings, INC. | $1,715.61 | 2019-2024 | Rosa, Mymobility Platform |
| Smith+Nephew, INC. | $1,045.85 | 2019-2024 | Real Intelligence, Journey II, R3 Acetabular |
| Medical Device Business Services, INC. | $710.89 | 2025 | Attune |
| Depuy Synthes Sales INC. | $382.03 | 2023-2025 | Na |
| Orthalign INC | $250.00 | 2025 | Orthalign Plus |
| Heron Therapeutics, INC. | $89.42 | 2024 | Zynrelef |
| Davol INC. | $85.50 | 2025 | Arista |
| Amgen INC. | $35.16 | 2022 | |
| Organogenesis INC. | $16.35 | 2024 | Puraply Wound Matrix |
| Merck Sharp & Dohme LLC | $14.57 | 2024 | Bridion |
| Illuminoss Medical, INC. | $8.40 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrin Trask listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.